Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
- Resource Type
- Article
- Authors
- Bartlett, Nancy L.; Assouline, Sarit; Giri, Pratyush; Schuster, Stephen J.; Cheah, Chan Y.; Matasar, Matthew; Gregory, Gareth P.; Yoon, Dok Hyun; Shadman, Mazyar; Fay, Keith; Yoon, Sung-Soo; Panizo, Carlos; Flinn, Ian; Johnston, Anna; Bosch, Francesc; Sehn, Laurie H.; Wei, Michael C.; Yin, Shen; To, Iris; Li, Chi-Chung; Huang, Huang; Kwan, Antonia; Penuel, Elicia; Budde, Lihua E.
- Source
- In Blood Advances 12 September 2023 7(17):4926-4935
- Subject
- Clinical Trials and Observations
Immunobiology and Immunotherapy
Lymphoid Neoplasia
- Language
- ISSN
- 2473-9529